交易 FibroGen, Inc - FGEN CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.04 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
FibroGen Inc ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 1.14 | -0.10 | -8.06% | 1.24 | 1.27 | 1.12 |
Apr 17, 2024 | 1.24 | -0.03 | -2.36% | 1.27 | 1.28 | 1.21 |
Apr 16, 2024 | 1.27 | 0.01 | 0.79% | 1.26 | 1.32 | 1.23 |
Apr 15, 2024 | 1.28 | 0.03 | 2.40% | 1.25 | 1.35 | 1.22 |
Apr 12, 2024 | 1.28 | -0.04 | -3.03% | 1.32 | 1.32 | 1.21 |
Apr 11, 2024 | 1.33 | -0.07 | -5.00% | 1.40 | 1.43 | 1.33 |
Apr 10, 2024 | 1.40 | -0.05 | -3.45% | 1.45 | 1.47 | 1.34 |
Apr 9, 2024 | 1.48 | -0.06 | -3.90% | 1.54 | 1.60 | 1.45 |
Apr 8, 2024 | 1.62 | 0.04 | 2.53% | 1.58 | 1.67 | 1.54 |
Apr 5, 2024 | 1.60 | 0.05 | 3.23% | 1.55 | 1.67 | 1.49 |
Apr 4, 2024 | 1.55 | 0.17 | 12.32% | 1.38 | 1.79 | 1.36 |
Apr 3, 2024 | 1.44 | -0.67 | -31.75% | 2.11 | 2.11 | 1.16 |
Apr 2, 2024 | 2.13 | -0.12 | -5.33% | 2.25 | 2.30 | 2.08 |
Apr 1, 2024 | 2.34 | 0.04 | 1.74% | 2.30 | 2.38 | 2.15 |
Mar 28, 2024 | 2.32 | -0.20 | -7.94% | 2.52 | 2.56 | 2.29 |
Mar 27, 2024 | 2.55 | 0.15 | 6.25% | 2.40 | 2.65 | 2.29 |
Mar 26, 2024 | 2.42 | -0.20 | -7.63% | 2.62 | 2.76 | 2.39 |
Mar 25, 2024 | 2.62 | 0.07 | 2.75% | 2.55 | 2.76 | 2.51 |
Mar 22, 2024 | 2.56 | 0.17 | 7.11% | 2.39 | 2.64 | 2.34 |
Mar 21, 2024 | 2.41 | 0.10 | 4.33% | 2.31 | 2.46 | 2.29 |
FibroGen, Inc Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 FibroGen Inc Earnings Release Q1 2024 FibroGen Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, June 6, 2024 | ||
時間 (UTC) 15:00 | 國家 US
| 事件 FibroGen Inc Annual Shareholders Meeting FibroGen Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Monday, August 5, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 FibroGen Inc Earnings Release Q2 2024 FibroGen Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 140.734 | 235.309 | 176.319 | 256.577 | 212.958 |
收入 | 140.734 | 235.309 | 176.319 | 256.577 | 212.958 |
總營業費用 | 441.759 | 523.839 | 368.199 | 345.891 | 299.651 |
銷售/一般/行政費用,總計 | 127.474 | 120.557 | 97.238 | 126.557 | 63.812 |
研究與開發 | 296.791 | 387.043 | 252.924 | 209.265 | 235.839 |
營業收入 | -301.025 | -288.53 | -191.88 | -89.314 | -86.693 |
利息收入(費用),非經營淨值 | 6.156 | -2.153 | 3.151 | 12.672 | 0.577 |
稅前淨收入 | -294.869 | -290.683 | -188.729 | -76.642 | -86.116 |
稅後淨收入 | -295.227 | -291.03 | -189.089 | -76.97 | -86.42 |
未計算非常項目前的淨收益 | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
淨收入 | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
普通股股東可獲收益 (不含非經常性項目) | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
普通股股東可獲收益 (含非經常性項目) | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
攤薄淨收入 | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
攤薄後加權平均股 | 93.582 | 92.349 | 89.854 | 86.633 | 84.062 |
扣除特別項目的每股攤薄盈利 | -3.13793 | -3.14051 | -2.10665 | -0.88846 | -1.02805 |
每股正常攤薄盈利 | -3.13793 | -3.14051 | -2.10665 | -0.88846 | -1.02805 |
非常規項目總計 | |||||
收入成本,共計 | 20.28 | 12.871 | 8.869 | 1.147 | |
毛利 | 120.454 | 222.438 | 167.45 | 255.43 | |
Depreciation / Amortization | 0.587 | 4.639 | 10.369 | 10.307 | |
Other Operating Expenses, Total | -3.373 | -1.271 | -1.201 | -1.385 | |
Equity In Affiliates | 1.573 | 1.007 | -0.202 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 44.319 | 36.161 | 34.367 | 15.735 | 29.806 |
收入 | 44.319 | 36.161 | 34.367 | 15.735 | 29.806 |
收入成本,共計 | 5.708 | 3.491 | 4.925 | 4.308 | 6.809 |
毛利 | 38.611 | 32.67 | 29.442 | 11.427 | 22.997 |
總營業費用 | 132.367 | 112.252 | 100.519 | 109.392 | 108.03 |
銷售/一般/行政費用,總計 | 31.181 | 34.275 | 33.966 | 29.902 | 30.258 |
研究與開發 | 95.478 | 74.486 | 61.628 | 75.182 | 70.963 |
Other Operating Expenses, Total | |||||
營業收入 | -88.048 | -76.091 | -66.152 | -93.657 | -78.224 |
利息收入(費用),非經營淨值 | -0.417 | -1.336 | -0.195 | 1.714 | 5.058 |
稅前淨收入 | -88.465 | -77.427 | -66.347 | -91.943 | -73.166 |
稅後淨收入 | -88.23 | -77.501 | -66.455 | -92.057 | -73.189 |
Equity In Affiliates | 0.55 | 0.796 | 0.28 | 0.407 | 0.565 |
未計算非常項目前的淨收益 | -87.68 | -76.705 | -66.175 | -91.65 | -72.624 |
淨收入 | -87.68 | -76.705 | -66.175 | -91.65 | -72.624 |
普通股股東可獲收益 (不含非經常性項目) | -87.68 | -76.705 | -66.175 | -91.65 | -72.624 |
普通股股東可獲收益 (含非經常性項目) | -87.68 | -76.705 | -66.175 | -91.65 | -72.624 |
攤薄淨收入 | -87.68 | -76.705 | -66.175 | -91.65 | -72.624 |
攤薄後加權平均股 | 97.729 | 94.691 | 94.035 | 93.767 | 93.475 |
扣除特別項目的每股攤薄盈利 | -0.89717 | -0.81006 | -0.70373 | -0.97742 | -0.77694 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.89717 | -0.81006 | -0.70373 | -0.97742 | -0.77694 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 492.826 | 474.059 | 755.11 | 702.49 | 690.015 |
現金和短期投資 | 422.008 | 405.19 | 686.537 | 533.757 | 621.402 |
現金 | 135.819 | 111.422 | 88.046 | 40.715 | 38.783 |
現金等價物 | 19.881 | 59.801 | 590.347 | 85.551 | 50.475 |
短期投資 | 266.308 | 233.967 | 8.144 | 407.491 | 532.144 |
應收賬款總額,淨額 | 16.299 | 25.401 | 41.883 | 153.665 | 63.684 |
應收賬款 - 貿易,淨額 | 28.387 | 36.331 | 46.01 | 158.51 | 16.474 |
預付的費用 | 9.73 | 7.383 | 8.353 | 6.464 | 4.929 |
總資産 | 610.087 | 773.821 | 826.84 | 857.397 | 880.598 |
物業/廠房/設備,總計 - 淨額 | 100.933 | 120.15 | 65.296 | 84.276 | 127.198 |
物業/廠房/設備,總計 - 總額 | 253.644 | 252.362 | 199.305 | 195.752 | 192.397 |
累計折舊,總計 | -152.711 | -132.212 | -134.009 | -111.476 | -65.199 |
長期投資 | 9.409 | 171.621 | 2.972 | 61.118 | 55.82 |
其他長期資産,總計 | 6.919 | 7.991 | 3.462 | 9.513 | 7.565 |
流動負債總額 | 273.562 | 225.497 | 163.187 | 102.745 | 89.033 |
應付賬款 | 30.758 | 26.097 | 24.789 | 6.088 | 9.139 |
預提費用 | 229.639 | 180.356 | 104.384 | 83.816 | 66.123 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 13.129 | 19.033 | 21.684 | 0.49 | 13.771 |
負債總額 | 631.534 | 564.675 | 404.662 | 341.262 | 371.399 |
長期債務總額 | 17.054 | 17.616 | 44.088 | 55.531 | 113.955 |
長期債務 | 16.917 | 17.613 | 18.697 | 16.78 | 16.798 |
資本租賃義務 | 0.137 | 0.003 | 25.391 | 38.751 | 97.157 |
少數股權 | 19.967 | 19.967 | 19.271 | 19.271 | 19.271 |
其他負債,總計 | 320.951 | 292.403 | 169.441 | 163.715 | 149.14 |
股權 | -21.447 | 209.146 | 422.178 | 516.135 | 509.199 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 0.942 | 0.929 | 0.914 | 0.877 | 0.854 |
額外實收資本 | 1541.02 | 1476.41 | 1399.77 | 1300.72 | 1226.45 |
留存收益(累計赤字) | -1557.69 | -1264.03 | -974.011 | -784.72 | -715.827 |
其他權益,總計 | -5.72 | -4.163 | -4.499 | -0.747 | -2.281 |
總負債和股東權益 | 610.087 | 773.821 | 826.84 | 857.397 | 880.598 |
已發行普通股總數 | 94.1661 | 92.881 | 91.441 | 87.657 | 85.432 |
總庫存 | 40.436 | 31.015 | 16.53 | 6.887 | |
其他流動資産,總計 | 4.353 | 5.07 | 1.807 | 1.717 | |
長期債務的當前部分/資本租賃 | 0.036 | 0.011 | 12.33 | 12.351 | |
遞延所得稅 | 9.192 | 8.675 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 364.108 | 411.357 | 430.549 | 492.826 | 474.224 |
現金和短期投資 | 251.34 | 335.716 | 355.949 | 422.008 | 408.52 |
現金 | 70.982 | 81.727 | 145.81 | 135.819 | 104.509 |
現金等價物 | 49.932 | 70.858 | 42.74 | 19.881 | 51.451 |
短期投資 | 130.426 | 183.131 | 167.399 | 266.308 | 252.56 |
應收賬款總額,淨額 | 31.694 | 25.599 | 17.654 | 16.299 | 15.328 |
應收賬款 - 貿易,淨額 | 54.61 | 45.55 | 29.217 | 28.387 | 29.665 |
總庫存 | 40.696 | 41.179 | 42.456 | 40.436 | 39.95 |
預付的費用 | 40.378 | 8.863 | 14.49 | 9.73 | 10.426 |
其他流動資産,總計 | 4.353 | ||||
總資産 | 460.426 | 515.127 | 538.544 | 610.087 | 608.837 |
物業/廠房/設備,總計 - 淨額 | 85.76 | 91.233 | 95.367 | 100.933 | 105.19 |
物業/廠房/設備,總計 - 總額 | 253.644 | ||||
累計折舊,總計 | -152.711 | ||||
長期投資 | 4.534 | 6.112 | 5.884 | 9.409 | 22.411 |
其他長期資産,總計 | 6.024 | 6.425 | 6.744 | 6.919 | 7.012 |
流動負債總額 | 209.415 | 194.072 | 254.746 | 273.562 | 251.994 |
應付賬款 | 19.22 | 12.802 | 71.282 | 30.758 | 19.323 |
預提費用 | 182.87 | 173.78 | 166.969 | 229.639 | 224.577 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.036 | ||||
其他流動負債,總計 | 7.325 | 7.49 | 16.495 | 13.129 | 8.094 |
負債總額 | 617.595 | 617.401 | 587.396 | 631.534 | 582.531 |
長期債務總額 | 88.608 | 88.773 | 17.276 | 17.054 | 15.422 |
長期債務 | 88.608 | 88.773 | 17.276 | 16.917 | 15.422 |
資本租賃義務 | 0.137 | ||||
遞延所得稅 | |||||
少數股權 | 41.967 | 41.967 | 19.967 | 19.967 | 19.967 |
其他負債,總計 | 277.605 | 292.589 | 295.407 | 320.951 | 295.148 |
股權 | -157.169 | -102.274 | -48.852 | -21.447 | 26.306 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
普通股 | 0.983 | 0.982 | 0.966 | 0.942 | 0.939 |
額外實收資本 | 1634.46 | 1625.07 | 1589.15 | 1541.02 | 1524.23 |
留存收益(累計赤字) | -1785.69 | -1722.07 | -1634.39 | -1557.69 | -1491.51 |
其他權益,總計 | -6.923 | -6.25 | -4.57 | -5.72 | -7.346 |
總負債和股東權益 | 460.426 | 515.127 | 538.544 | 610.087 | 608.837 |
已發行普通股總數 | 98.3391 | 98.2042 | 96.623 | 94.1661 | 93.936 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -293.654 | -290.023 | -189.291 | -76.97 | -86.42 |
經營活動産生的現金 | -145.933 | -82.232 | 81.602 | -78.705 | -76.144 |
經營活動産生的現金 | 10.604 | 14.809 | 22.047 | 21.454 | 6.562 |
非現金物品 | 66.687 | 132.899 | 74.216 | 62.47 | 52.112 |
已付現金利息 | 0.104 | 0.094 | 0.135 | 0.174 | 0.218 |
營運資金的變化 | 70.43 | 60.083 | 174.63 | -85.659 | -48.398 |
投資活動産生的現金 | 89.116 | -426.972 | 452.487 | 120.018 | -522.123 |
資本支出 | -38.741 | -30.186 | -3.994 | -5.762 | -8.02 |
其他投資現金流量項目,總計 | 127.857 | -396.786 | 456.481 | 125.78 | -514.103 |
融資活動産生的現金 | 46.776 | -0.563 | 13.343 | -4.3 | 13.875 |
融資現金流項目 | -6.62 | -7.372 | -11.463 | -12.75 | -15.612 |
股票的發行(報廢),淨額 | 53.934 | 12.701 | 37.829 | 20.778 | 29.847 |
債務的發行(退還),淨額 | -0.538 | -5.892 | -13.023 | -12.328 | -0.36 |
外彙效應 | -5.482 | 2.597 | 4.695 | -0.005 | -0.008 |
現金淨變化 | -15.523 | -507.17 | 552.127 | 37.008 | -584.4 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -76.705 | -293.654 | -227.479 | -135.829 | -63.205 |
Cash From Operating Activities | -101.591 | -145.933 | -93.42 | -41.54 | -8.476 |
Cash From Operating Activities | 2.965 | 10.604 | 7.914 | 5.235 | 2.584 |
Non-Cash Items | 18.148 | 66.687 | 49.928 | 34.441 | 17.77 |
Changes in Working Capital | -45.999 | 70.43 | 76.217 | 54.613 | 34.375 |
Cash From Investing Activities | 103.482 | 89.116 | 88.023 | 43.24 | 25.935 |
Capital Expenditures | -0.591 | -38.741 | -38.408 | -37.543 | -36.638 |
Other Investing Cash Flow Items, Total | 104.073 | 127.857 | 126.431 | 80.783 | 62.573 |
Cash From Financing Activities | 31.485 | 46.776 | -1.898 | -0.806 | -2.893 |
Financing Cash Flow Items | 0 | -6.62 | -4.562 | -3.361 | -2.974 |
Issuance (Retirement) of Stock, Net | 31.657 | 53.934 | 2.989 | 2.779 | 0.183 |
Issuance (Retirement) of Debt, Net | -0.172 | -0.538 | -0.325 | -0.224 | -0.102 |
Foreign Exchange Effects | -0.526 | -5.482 | -7.968 | -4.359 | 0.107 |
Net Change in Cash | 32.85 | -15.523 | -15.263 | -3.465 | 14.673 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
409 Illinois Street
SAN FRANCISCO
CALIFORNIA 94158
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易